Remodeling Tumor-Associated Macrophages and Neovascularization Overcomes EGFRT790M -Associated Drug Resistance by PD-L1 Nanobody-Mediated Codelivery
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Remodeling Tumor-Associated Macrophages and Neovascularization Overcomes EGFRT790M
-Associated Drug Resistance by PD-L1 Nanobody-Mediated Codelivery
Authors
Keywords
-
Journal
Small
Volume 14, Issue 47, Pages 1802372
Publisher
Wiley
Online
2018-10-11
DOI
10.1002/smll.201802372
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Redundant angiogenic signaling and tumor drug resistance
- (2018) Rajesh N. Gacche et al. DRUG RESISTANCE UPDATES
- Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR -mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study
- (2018) Wen-Zhao Zhong et al. LANCET ONCOLOGY
- Dual-targeting biomimetic delivery for anti-glioma activity via remodeling the tumor microenvironment and directing macrophage-mediated immunotherapy
- (2018) Pengfei Zhao et al. Chemical Science
- Regulation of PD-L1: Emerging Routes for Targeting Tumor Immune Evasion
- (2018) Yiting Wang et al. Frontiers in Pharmacology
- Reprogramming Tumor-Associated Macrophages To Reverse EGFRT790M Resistance by Dual-Targeting Codelivery of Gefitinib/Vorinostat
- (2017) Huige Peng et al. NANO LETTERS
- Programmed death ligand 1 (PD-L1) expression and tumor microenvironment: Implications for patients with oral precancerous lesions
- (2017) Takahiro Yagyuu et al. ORAL ONCOLOGY
- Statin improves survival in patients with EGFR-TKI lung cancer: A nationwide population-based study
- (2017) Ming-Szu Hung et al. PLoS One
- Reversing EGFR Mediated Immunoescape by Targeted Monoclonal Antibody Therapy
- (2017) Fernando Concha-Benavente et al. Frontiers in Pharmacology
- In situ activation of platelets with checkpoint inhibitors for post-surgical cancer immunotherapy
- (2017) Chao Wang et al. Nature Biomedical Engineering
- Generation of Small Single Domain Nanobody Binders for Sensitive Detection of Testosterone by Electrochemical Impedance Spectroscopy
- (2016) Guanghui Li et al. ACS Applied Materials & Interfaces
- Targeting Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer by Inducing Epidermal Growth Factor Receptor Degradation via Methionine 790 Oxidation
- (2016) Elaine Lai-Han Leung et al. ANTIOXIDANTS & REDOX SIGNALING
- The impact of hypoxia on tumor-associated macrophages
- (2016) Anne-Theres Henze et al. JOURNAL OF CLINICAL INVESTIGATION
- The effect of statins on survival in patients with stage IV lung cancer
- (2016) Jenny J. Lin et al. LUNG CANCER
- Enhanced Cancer Immunotherapy by Microneedle Patch-Assisted Delivery of Anti-PD1 Antibody
- (2016) Chao Wang et al. NANO LETTERS
- Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors
- (2016) Yong Jia et al. NATURE
- PARP Inhibition Suppresses Growth of EGFR-Mutant Cancers by Targeting Nuclear PKM2
- (2016) Nan Li et al. Cell Reports
- Construction of a biotinylated cameloid-like antibody for lable-free detection of apolipoprotein B-100
- (2015) Henan Li et al. BIOSENSORS & BIOELECTRONICS
- Statin Use and Survival from Lung Cancer: A Population-Based Cohort Study
- (2015) C. R. Cardwell et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Liposomal simvastatin inhibits tumor growth via targeting tumor-associated macrophages-mediated oxidative stress
- (2015) Marius Costel Alupei et al. CANCER LETTERS
- Genetic instability in the tumor microenvironment: a new look at an old neighbor
- (2015) Antonio Palumbo et al. Molecular Cancer
- Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M
- (2015) Kenneth S Thress et al. NATURE MEDICINE
- Microenvironmental regulation of therapeutic response in cancer
- (2015) Florian Klemm et al. TRENDS IN CELL BIOLOGY
- Macrophages and cancer: from mechanisms to therapeutic implications
- (2015) Renato Ostuni et al. TRENDS IN IMMUNOLOGY
- A lovastatin-elicited genetic program inhibits M2 macrophage polarization and enhances T cell infiltration into spontaneous mouse mammary tumors
- (2015) Emilia Mira et al. Oncotarget
- The regulatory peptide pidotimod facilitates M2 macrophage polarization and its function
- (2014) Shenglan Hu et al. AMINO ACIDS
- HIF Transcription Factors, Inflammation, and Immunity
- (2014) Asis Palazon et al. IMMUNITY
- Hypoxia-inducible factors in regulation of immune responses in tumour microenvironment
- (2014) Vinit Kumar et al. IMMUNOLOGY
- Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs
- (2014) Mark G. Kris et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A general protocol for the generation of Nanobodies for structural biology
- (2014) Els Pardon et al. Nature Protocols
- Galectin-3 disruption impaired tumoral angiogenesis by reducing VEGF secretion from TGFβ1-induced macrophages
- (2014) Camila Maria Longo Machado et al. Cancer Medicine
- Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis
- (2014) Vladimir Riabov et al. Frontiers in Physiology
- A Mechanism of Hypoxia-Mediated Escape from Adaptive Immunity in Cancer Cells
- (2013) I. B. Barsoum et al. CANCER RESEARCH
- Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling
- (2012) Paul D. Ray et al. CELLULAR SIGNALLING
- Macrophage plasticity and polarization: in vivo veritas
- (2012) Antonio Sica et al. JOURNAL OF CLINICAL INVESTIGATION
- The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes
- (2010) F. Bellora et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancers Dependent on the Epidermal Growth Factor Receptor Pathway
- (2009) Kim-Son H. Nguyen et al. Clinical Lung Cancer
- Crosstalk Between Vascular Endothelial Growth Factor, Notch, and Transforming Growth Factor-β in Vascular Morphogenesis
- (2008) Matthew T. Holderfield et al. CIRCULATION RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now